On July 11, 2024, Affluent Medical reached a major milestone with the signature of several agreements with Edwards Lifesciences, a global MedTech player, recognizing the relevance and potential of the ...

Tariff talk will continue in the second week of earnings season, but the updates could also shed light on trends and ...

Ferenc Jakab underwent groundbreaking robotic heart surgery, which offered a faster recovery and less trauma. But how often ...

The Apollo Institute of Robotic Surgery was launched in June, 2012 and has been performing a good number of robotic surgeries with the Da-Vinci Robotic Surgical System. The Hospital commissioned ...

After acquiring its developer last year, Edwards Lifesciences has now obtained a European approval for what it described as ...

The first-of-its-kind Edwards Lifesciences Sapien M3 TMVR system uses a nitinol dock to anchor the replacement valve in the ...

Edwards Lifesciences Corp.’s Sapien M3 secured CE mark for its Sapien M3 mitral valve replacement system for transfemoral treatment of patients with mitral valve disease who are ineligible for surgery ...

Edwards Lifesciences has received Europe’s CE mark for its transcatheter mitral valve replacement system, Sapien M3, the company said Monday. The device is designed for people with symptomatic ...